Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Enanta Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

Validea Guru Analysis Report for ENTA. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

26 Aug 2016 Validea 0 $12.00

Thomson Reuters Stock Report - Enanta Pharmaceuticals Inc (ENTA-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 Aug 2016 Thomson Reuters Stock Report 12 $25.00

Value Graph: ENANTA PHARMA -- ENTA

26 Aug 2016 Ford Investor Services, Inc. 1 $12.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ENANTA PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

26 Aug 2016 Jefferson Research 11 $20.00

ENANTA PHARMACEUTICALS INC (ENTA=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

20 Aug 2016 Pechala's Reports 2 $25.00

Wright Investors Service Comprehensive Report for Enanta Pharmaceuticals Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

19 Aug 2016 Wright Reports 59 $75.00

Enanta Pharmaceuticals, Inc. (ENTA) - Financial Analysis Review

Enanta Pharmaceuticals, Inc. (ENTA) - Financial Analysis Review Summary Enanta Pharmaceuticals, Inc. (Enanta) is a biotechnol...

17 Aug 2016 GlobalData 32 $300.00

ValuEngine Rating and Forecast Report for ENTA

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

14 Aug 2016 ValuEngine, Inc. 11 $25.00

ENTA.OQ - Event Transcript of Enanta Pharmaceuticals Inc conference call, Aug. 08, 2016 / 4:30PM ET

Edited Event Transcript of ENTA.OQ conference call, Aug. 08, 2016 / 4:30PM ET Boston, Aug 8, 2016 (Thomson StreetEvents...

08 Aug 2016 Thomson Reuters StreetEvents 7 $75.00